Check out your Company Bowl for anonymous work chats.
We are thrilled to announce that in collaboration with the Broad Institute of MIT and Harvard, DataTecnica, Northwestern University Feinberg School of Medicine, Sage Bionetworks, Technome, and Vanderbilt University Medical Center, Verily has secured a two-year renewal for the NIH System Biology (SysBio) award. This $9.2 million in continued funding will further the development and implementation of the FAIRplex platform, empowering researchers to efficiently find, access, and analyze data from Accelerating Medicines Partnership® (AMP®) projects and beyond. The platform will help foster a deeper understanding of the systems biology underpinning human health and disease. "This renewed funding underscores the critical importance of creating a unified, accessible, and secure data ecosystem as researchers look to apply advanced AI and machine learning techniques to accelerate scientific findings," says Andrew Trister, MD, PhD, Chief Medical and Scientific Officer at Verily.
Advanced wastewater monitoring empowers public health officials with insights for rapid and targeted disease response. Watch our on-demand webinar to hear real-world success stories from public health experts in Hawaii and Texas, who leveraged wastewater monitoring in their H5N1 responses.
Andrew Trister, our Chief Medical and Scientific Officer, reflected on 2025 innovations at Verily, highlighting the launches of Verily Pre, our precision health platform, and Verily Me, our consumer health app. Both efforts align with the growing focus on using health data to drive personalized, actionable insights.
Data from the Centers for Disease Control and Prevention shows a rise in positive norovirus cases across the country. Wastewater surveillance offers the most real-time view of what's circulating in a community for diseases like flu, RSV, COVID-19, and norovirus. Verily is working on the front lines of this effort, including at a treatment site in Indiana, where there has been a spike in cases. Read more and how to stay safe during the holidays.
GLP-1s have transformed cardiometabolic care, yet major blind spots remain because traditional health data shows what happens, but not always why. Verily Viewpoint Evidence is helping close critical data gaps through an ongoing, real-world view of health, enabling researchers to uncover drivers of disease, treatment response, and wellbeing. From revealing the mechanisms of GLP-1s for cardiometabolic care to exploring other pharmacologic potential, Verily is advancing precision evidence for research, and setting a new standard for real-world understanding.
Fragmented data hinders biopharma R&D. Learn how a trusted research environment (TRE) can unify your complex healthcare data.
"As we look to the idea of an 'AI doctor' to help fill care gaps, we can take lessons from the path of self-driving cars, and Waymo. Technology alone is not going to get us there. We will need alignment and coordination with regulatory agencies, clinicians, and the current healthcare system to make progress." Stephen Gillett, Verily CEO, spoke with Alec C. Kimmelman, MD, PhD of NYU Langone Health, Trent Norris of NVIDIA and moderator Katharine Schwab about improving the patient experience at the Forbes Healthcare Summit today, noting our new consumer health app, Verily Me: "Health search is quickly dropping off. People are turning to LLMs. We launched Verily Me, which allows you to get personalized care recommendations from clinicians. With our AI companion called Violet, you can have a conversation about your labs and medical records from across your providers, as you go through your care journey. We are committed to bringing precision health to patients everywhere, every day. That's what we're trying to do with Verily Me."
Healthcare data errors can snowball, jeopardizing patient care. That's why our FHIR-native platform, Verily Pre, is built to implement quality checks in real-time — assessing data at the source to preserve original lineage and traceability. Standard FHIR validation fails at the resource level; it can't detect contradictory stories from linked resources. Learn about the importance of robust multi-resource FHIR validation using FHIRPath for simple checks and Clinical Quality Language (CQL) for complex rules. Eliminate data quality errors, boost interoperability, and halt the "snowball effect" for good.
It was an honor to be recognized as one of the 50 innovators transforming healthcare at the Fierce 50 Awards Gala! Amy Lockwood, our Head of Public Health Partnerships, accepted the award for the work we’re doing to understand what pathogens are circulating in communities to prevent the spread of infectious disease.
Don't miss the panel "Bringing Cutting-Edge Technology To Patient Care" at the Forbes 2025 Healthcare Summit on December 4 at 11:30 AM EST in New York. The session, featuring our CEO, Stephen Gillett, Alec C. Kimmelman, MD, PhD of NYU Langone Health, Trent Norris of NVIDIA and moderated by Katharine Schwab, Assistant Managing Editor, Technology at Forbes will explore how advances in big data and artificial intelligence can improve the patient experience across care.
